266 related articles for article (PubMed ID: 36063207)
1. A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Hong Y; Huang W; Cao D; Xu J; Wei H; Zhang J; Wang L
Psychopharmacology (Berl); 2022 Oct; 239(10):3367-3375. PubMed ID: 36063207
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
[TBL] [Abstract][Full Text] [Related]
3. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole alone or in combination for acute mania.
Brown R; Taylor MJ; Geddes J
Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
[TBL] [Abstract][Full Text] [Related]
5. Haloperidol alone or in combination for acute mania.
Cipriani A; Rendell JM; Geddes JR
Cochrane Database Syst Rev; 2006 Jul; (3):CD004362. PubMed ID: 16856043
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.
Cipriani A; Barbui C; Salanti G; Rendell J; Brown R; Stockton S; Purgato M; Spineli LM; Goodwin GM; Geddes JR
Lancet; 2011 Oct; 378(9799):1306-15. PubMed ID: 21851976
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and network meta-analysis on comparative efficacy, acceptability, and safety of treatments in acute bipolar mania in youths.
Tural Hesapcioglu S; Kasak M; Abursu H; Kafali S; Ceylan MF; Akyol M
J Affect Disord; 2024 Mar; 349():438-451. PubMed ID: 38211745
[TBL] [Abstract][Full Text] [Related]
8. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
[TBL] [Abstract][Full Text] [Related]
9. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia.
Yu CL; Carvalho AF; Thompson T; Tsai TC; Tseng PT; Hsu CW; Hsu TW; Liang CS
BMJ Ment Health; 2023 Feb; 26(1):. PubMed ID: 36789916
[TBL] [Abstract][Full Text] [Related]
11. Lithium for acute mania.
McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Lazarus A
Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
[TBL] [Abstract][Full Text] [Related]
13. Variability and efficacy in treatment effects on manic symptoms with lithium, anticonvulsants, and antipsychotics in acute bipolar mania: A systematic review and meta-analysis.
Hsu TW; Thompson T; Solmi M; Vieta E; Yang FC; Tseng PT; Hsu CW; Tu YK; Yu CL; Tsai CK; Liang CS; Carvalho AF
EClinicalMedicine; 2022 Dec; 54():101690. PubMed ID: 36247926
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
15. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Taylor DM; Cornelius V; Smith L; Young AH
Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
[TBL] [Abstract][Full Text] [Related]
17. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Goikolea JM; Colom F; Torres I; Capapey J; Valentí M; Undurraga J; Grande I; Sanchez-Moreno J; Vieta E
J Affect Disord; 2013 Jan; 144(3):191-8. PubMed ID: 23089129
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.
Yildiz A; Vieta E; Leucht S; Baldessarini RJ
Neuropsychopharmacology; 2011 Jan; 36(2):375-89. PubMed ID: 20980991
[TBL] [Abstract][Full Text] [Related]
19. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Gao K; Ganocy SJ; Gajwani P; Muzina DJ; Kemp DE; Calabrese JR
J Clin Psychiatry; 2008 Feb; 69(2):302-9. PubMed ID: 18211129
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
Srisurapanont M; Likhitsathian S; Suttajit S; Maneeton N; Maneeton B; Oon-Arom A; Suradom C
Drug Alcohol Depend; 2021 Feb; 219():108467. PubMed ID: 33385693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
